CIPO Patents = 1

EPO Patents = 4

Forward Citations = 3

Loading Chart...

6 inventors (with patents filed for the assignee):

Hesheng Zhang (5 out of 34 patents)

Yingwei Chen (3 out of 5 patents)

Aihong Huo (2 out of 2 patents)

4. Zhenzhong Li (2 out of 2 patents)

5. Qingchao He (2 out of 3 patents)

6. Guanghuai Zeng (1 out of 8 patents)

5 patents: Sort by Forward Citations

1. 10294260 - Tetracyclic anthraquinone derivatives (2019-05-21),

2. 10246443 - Cyanoquinoline derivatives (2019-04-02),

3. 9840494 - Quinazoline derivative (2017-12-12),

4. 9676724 - Cyanoquinoline derivatives (2017-06-13),

5. 9670242 - Tetracyclic anthraquinone derivatives (2017-06-06),

Tianjin Hemay Oncology Pharmaceutical Co., Ltd. is a leading oncology pharmaceutical company dedicated to research, development, and commercialization of innovative cancer treatments. With a strong focus on precision medicine, Hemay Oncology aims to provide cutting-edge therapies for patients worldwide. The company's portfolio includes a variety of targeted therapies and immunotherapies to address the diverse needs of cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#53 in Tianjin

#4,601 in China

Tianjin, China

Tianjin Hemay Oncology Pharmaceutical Co., Ltd.

Forward Citations = 3

6 inventors:

Hesheng Zhang (5 out of 34 patents)

Yingwei Chen (3 out of 5 patents)

Aihong Huo (2 out of 2 patents)

4. Zhenzhong Li (2 out of 2 patents)

5. Qingchao He (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com